The best aesthetic clinics don’t stop at fat reduction. Discover how to create an effective lineup of complementary body contouring treatments that deliver on patient satisfaction and retention.
July 26, 2019
TEL: (888) 907-0115
Venus Concept is a leader in the global medical and aesthetic device market, pairing best-in-class technology with the first and only true subscription model in the industry.
Body contouring and fat reduction are two of the most sought-after treatments. According to the American Society of Plastic Surgeons’ 2018 Plastic Surgery Statistics Report, demand for liposuction and similar treatments increased five percent year-over-year. Further to that, the report notes that the number of minimally invasive treatments performed in the United States in 2018 outpaced surgical procedures across all demographics by a range of 250% to 1,275%. Complementary non-invasive aesthetic treatments that support patients’ body goals are expected to continue to grow in tandem with consumers’ demand for a healthy lifestyle. With these trends in mind, incorporating non-invasive lipolysis treatments into your aesthetics practice could boost future growth opportunities. Here’s how to get started.
While investing in a new device can be a nerve-wracking experience, warranty considerations included, understanding your clinic’s budget and how you plan to finance the purchase is the first step to narrowing your options. Having a limited budget doesn’t mean that you need to limit your options. Opting for a device with changeable applicators, for example, is one creative way to get more for your money, allowing your clinic to offer complementary treatments for optimal outcomes for just the cost of an additional applicator, rather than a whole new device. Furthermore, opting for a subscription-based payment plan (like the one Venus Concept offers) can help to keep regular costs in check with profits, offering predictable payments that work with your cash flow.
Another key factor to consider is device placement. Will all treatments be performed in one room or is it better to have a compact device that can be easily moved between rooms? The latter contributes to a flexible workflow enabling you to prioritize patient comfort. In other words, a compact device could benefit clinics who prefer the convenience of mobility within a smaller square footage. Also, when opting for a multi-treatment device, the extra space saved may be used to improve other aspects of your clinic’s offerings, such as increased room for patient comfort, a staff relaxation room to raise team morale, or a dedicated space for before-and-after photos to improve your marketing materials.
Obtaining the most innovative technology enables you to achieve optimal efficacy for each patient. Venus Bliss™, for instance, uses diode laser technology to target unwanted fat, and an (MP)2 applicator that synergistically combines Multi-Polar Radio Frequency (RF) and Pulsed Electro Magnetic Fields (PEMF) with VariPulse™ technology to tighten skin*, reduce circumference*, and target cellulite. Each of the four diode laser applicators may be activated individually and placed in various configurations on a belt for fully customizable treatment options. The VariPulse™ technology, integrated within the (MP)2 applicator, offers adjustable pulsed suction to facilitate a deep effect on adipose tissue. With VariPulse™, your clinic can better reach and maintain a therapeutically effective temperature faster while ensuring patient comfort. Understanding these details allows you to see how the addition of this device may benefit your clinic and offer the options you need to achieve each patient’s unique body aesthetic goals.
The last and final step, following your device purchase and staff training, is to introduce your new device to current and prospective patients. Launching an announcement utilizing your email marketing list or inviting patients, friends, and family to attend a launch event can help to create excitement and buzz surrounding your new service offerings. Further, designing creative marketing assets is essential across print and digital platforms to generate interest around your new services. In some cases, it may be easier to hire a team of professionals to help you execute a robust marketing strategy without cutting corners.
Finally, ensure all treatment providers are well-versed with the benefits of your new fat treatment system and are able to compellingly convey value to patients. For example, with its two treatment modalities, Venus Bliss™ offers the benefits of non-invasive lipolysis resulting in fat reduction as well as the smoothing effects of the (MP)2 applicator to achieve a more contoured appearance.
Interested in learning more about Venus Bliss™ and the benefits of a Venus Concept partnership? Contact an expert today!
* Temporary skin tightening and temporary circumferential reduction are approved indications in Canada.
.png)
For more information call: (888) 907-0115 // info@venusconcept.com // 235 Yorkland Blvd., Suite 900, Toronto, ON, M2J 4Y8 Canada
REGULATORY CLEARANCES [ More ]
Venus Bliss™ is cleared by the FDA and licensed by Health Canada for non-invasive lipolysis of the abdomen and flanks in individuals with a Body Mass Index (BMI) of 30 or less, with the diode laser applicators. The (MP)2 applicator is cleared by the FDA for temporary reduction in the appearance of cellulite, and licensed by Health Canada for temporary increase of skin tightening, temporary circumferential reduction, and temporary cellulite reduction. Venus Bliss™ has CE Mark as a non-invasive medical aesthetic device enabling a comprehensive approach leading to body contouring, addressing fat reduction, skin tightening, circumference reduction, and cellulite reduction.
Venus Versa™ is cleared by the FDA, licensed by Health Canada, and has CE Mark as a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the treatment of benign pigmented epidermal and cutaneous lesions and treatment of benign cutaneous vascular lesions. The HR650/HR650XL and HR690/HR690XL applicators are cleared by the FDA, licensed by Health Canada, and have CE Mark for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for Fitzpatrick skin types I-IV. The AC Dual applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for the treatment of acne vulgaris. The DiamondPolar™ and OctiPolar™ applicators on the Venus Versa™ system are cleared by the FDA for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The DiamondPolar™ applicator is licensed by Health Canada and has CE Mark for non-invasive treatment of moderate to severe facial wrinkles and rhytides on females with Fitzpatrick skin types I-IV. The OctiPolar™ applicator on the Venus Versa™ system is licensed by Health Canada and has CE Mark for temporary body contouring via skin tightening, circumferential reduction, and cellulite reduction. The NanoFractional RF™ (Viva) applicator is cleared by the FDA, licensed by Health Canada, and has CE Mark for dermatological procedures requiring ablation and resurfacing of the skin.
ARTAS iX™ is cleared by the FDA, licensed by Health Canada and has CE Mark with indication for use for harvesting hair follicles from the scalp in men diagnosed with androgenic alopecia (male pattern hair loss) who have black or brown straight hair. ARTAS iX™ is intended to assist physicians in identifying and extracting hair follicular units from the scalp during hair transplantation; creating recipient sites; and implanting harvested hair follicles.
NeoGraft® is cleared by the FDA, licensed by Health Canada and has CE Mark with indication for use in suction-assisted follicular extraction and re-implantation. NeoGraft® is an auto-graft system and can be used on both male and female patients.
Venus Legacy™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV with the OctiPolar™ and DiamondPolar™ applicators, and temporary reduction in the appearance of cellulite with the 4D Body (LB2) and 4D Face (LF2) applicators. It is licensed by Health Canada and has CE Mark for the temporary increase of skin tightening, temporary circumferential reduction, temporary cellulite reduction, and temporary wrinkle reduction.
Venus Velocity™ is cleared by the FDA, licensed by Health Canada and has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types.
Venus Fiore™ received regulatory approval in Israel for aesthetic and functional treatment of the vagina, labia and mons pubis. Venus Fiore™ is available for sale in India, Hong Kong, and other selected Asian countries.
The Venus Viva™ MD is cleared by the FDA, licensed by Health Canada and has CE Mark for the use in dermatological procedures requiring ablation and resurfacing of the skin using the Viva™/Viva™ MD applicator, and the non-invasive treatment, reduction in the appearance of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
The Venus Viva™ MD is cleared by the FDA for the use in dermatological procedures requiring ablation and resurfacing of the skin, and the non-invasive treatment of moderate to severe facial wrinkles and rhytides for females in Fitzpatrick skin types I-IV with the DiamondPolar™ applicator.
Venus Epileve™ is cleared by FDA, licensed by Health Canada and has CE Mark for hair removal, permanent hair reduction (defined as the long-term stable reduction in the number of hairs re-growing when measured at 6, 9 and 12 months after the completion of a treatment regimen), and the treatment of pseudofolliculitis barbae for all Fitzpatrick skin types. Venus Epileve™ is also CE-Marked for hirsutism.
Venus Freeze Plus™ is cleared by the FDA for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in females with Fitzpatrick skin types I-IV. It is licensed by Health Canada for temporary skin tightening, and temporary reduction in the appearance of cellulite on the abdomen and flanks, using the DiamondPolar™ and OctiPolar™ applicators. The DiamondPolar™ applicator on Venus Freeze Plus™ has CE Mark for the non-invasive treatment of moderate to severe facial wrinkles and rhytides, and the increase of skin tightening, temporary circumferential reduction, and cellulite reduction with the OctiPolar™ applicator.
Venus Heal™ is licensed by Health Canada and can be used for the treatment of both acute and chronic disorders of the musculoskeletal system, such as muscle spasms, back pain, and soft tissue injuries, and results in effects such as pain relief, myorelaxation, increase of local blood circulation, and edema reduction. In the U.S., Venus Heal™ is cleared by the FDA for the relief of minor muscle aches and pain, relief of muscle spasm, and temporary improvement of local blood circulation. These indications enable the treatment of certain soft tissue injuries and conditions.
Venus Glow™ is cleared by the FDA as a Class I motorized dermabrasion device. It provides a dermal rejuvenation treatment that works to open up and deep-clean pores. Venus Concept is the exclusive distributor for Venus Glow™.
Venus Skin™ is a skin care line of various lotions and creams intended to improve different aspects of skin appearance, skin serums, and skin nourishment solutions.
Copyright 2023 Venus Concept. All rights reserved.
You are entering our website. For other countries/regions and language options, please click the SELECT A DIFFERENT REGION button below.
SELECT A DIFFERENT REGIONAre you looking to get a treatment? Please visit our patient website to learn more.
Click HereBe aware of schemes involving fraudulent job postings.
Read More